Ideaya Biosciences Inc is trading 5.6% up today at $32.99, rebounding from levels seen following its recently priced equity offering.
- The company announced a $300 million underwritten public offering of common stock and pre-funded warrants on June 8, 2026.
- Capital raised from the offering is intended to strengthen the balance sheet and accelerate the development of the company's clinical pipeline.
- Investors are reassessing the stock positively as it moves significantly higher than the $27.00 deal price, indicating strong post-offering demand.